论文部分内容阅读
前列腺增生症（BPH）是中老年男性的常见病，多发病。多发于50岁以上的老年人，据欧美等国统计，在老年男性中其发病率高达80％以上；国内报导较低，但也达50％以上[1]。BPH带来的社会影响和经济负担已引人注目，研究工作日益深入，本文就BPH病因研究及药物治疗进展作一概述。1
Benign prostatic hyperplasia (BPH) is a common and frequently-occurring disease in middle-aged and elderly men. Occurred in the elderly over the age of 50, according to statistics of Europe and the United States and other countries, the incidence of older men in the incidence of up to 80%; domestic coverage is low, but also up to 50%. The social and economic burdens brought by BPH have attracted people’s attention and research work has become more and more in-depth. This article gives an overview of the etiology of BPH and the progress of drug treatment. 1